Short Interest in Greenland Mines Ltd. Common Stock (NASDAQ:GRML) Declines By 92.1%

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) was the target of a large decrease in short interest in August. As of August 31st, there was short interest totaling 643,675 shares, a decrease of 92.1% from the August 15th total of 8,112,226 shares. Approximately 22.8% of the shares of the company are short sold. Based on an average trading volume of 927,244 shares, the short-interest ratio is presently 0.7 days.

Insider Activity at Greenland Mines Ltd. Common Stock

In other news, Director Jason David Sawyer acquired 4,800 shares of Greenland Mines Ltd. Common Stock stock in a transaction that occurred on Wednesday, July 22nd. The shares were purchased at an average cost of $11.50 per share, for a total transaction of $55,200.00. Following the completion of the purchase, the director directly owned 4,800 shares of the company’s stock, valued at $55,200. This trade represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO Jeff Leblanc acquired 14,000 shares of Greenland Mines Ltd. Common Stock stock in a transaction that occurred on Tuesday, August 25th. The shares were purchased at an average price of $9.72 per share, for a total transaction of $136,080.00. Following the completion of the purchase, the chief financial officer directly owned 110,406 shares of the company’s stock, valued at $1,073,146.32. The trade was a 14.52% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 11.30% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the business. Jane Street Group LLC bought a new position in shares of Greenland Mines Ltd. Common Stock in the second quarter worth $26,000. Geode Capital Management LLC lifted its holdings in Greenland Mines Ltd. Common Stock by 51.8% in the fourth quarter. Geode Capital Management LLC now owns 491,832 shares of the company’s stock worth $142,000 after purchasing an additional 167,905 shares during the period. Renaissance Technologies LLC bought a new position in Greenland Mines Ltd. Common Stock in the 4th quarter valued at about $126,000. XTX Topco Ltd grew its position in Greenland Mines Ltd. Common Stock by 101.2% in the 4th quarter. XTX Topco Ltd now owns 160,569 shares of the company’s stock valued at $46,000 after buying an additional 80,768 shares in the last quarter. Finally, Citadel Advisors LLC acquired a new position in Greenland Mines Ltd. Common Stock during the 2nd quarter valued at about $1,343,000. Institutional investors and hedge funds own 20.07% of the company’s stock.

Greenland Mines Ltd. Common Stock Stock Performance

Shares of NASDAQ:GRML traded down $0.23 during trading hours on Friday, hitting $3.59. The stock had a trading volume of 327,510 shares, compared to its average volume of 159,985. The stock’s fifty day simple moving average is $8.84 and its 200 day simple moving average is $16.97. The firm has a market capitalization of $11.41 million, a price-to-earnings ratio of -0.31 and a beta of 6.91. Greenland Mines Ltd. Common Stock has a 1-year low of $3.52 and a 1-year high of $36.99.

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) last issued its quarterly earnings data on Monday, August 17th. The company reported ($0.03) earnings per share (EPS) for the quarter.

Analyst Ratings Changes

GRML has been the topic of a number of recent research reports. Weiss Ratings downgraded shares of Greenland Mines Ltd. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday. Wall Street Zen upgraded shares of Greenland Mines Ltd. Common Stock to a “sell” rating in a research note on Saturday, August 29th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has a consensus rating of “Sell”.

About Greenland Mines Ltd. Common Stock

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases – cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.